Volume 21, Number 8—August 2015
Letter
Measles Vaccination Coverage and Cases among Vaccinated Persons
Figure

Figure. Relationship between vaccination coverage with >1 doses and the proportion of measles case-patients who had been vaccinated. The observed numbers of vaccinated case-patients can be used to infer the vaccination coverage for different populations. Of 62 (21.0%) measles case-patients with known vaccination status in California, USA, 13 had received >1 doses (6). Of 230 (13.0%) case-patients with known vaccination status in the United States during January–May 2014, a total of 30 had received >1 doses (7). Vaccine effectiveness is assumed to be 99% (3,4). The shaded areas for the countries of the European Union (EU) and European Economic Area (EEA), and Switzerland correspond to the 95% CIs. 95% CIs are omitted for California and the United States because of the small sample sizes.
References
- Centers for Disease Control and Prevention. Measles cases and outbreaks [cited 2015 Feb 13]. http://www.cdc.gov/measles/cases-outbreaks.html
- European Centre for Disease Prevention and Control. Surveillance report, measles and rubella monitoring, February 2014 [cited 2015 Apr 8]. http://ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-february-2014.pdf
- Wichmann O, Hellenbrand W, Sagebiel D, Santibanez S, Ahlemeyer G, Vogt G, Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J. 2007;26:782–6. DOIPubMedGoogle Scholar
- van Boven M, Kretzschmar M, Wallinga J, O’Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7:1537–44.PubMedGoogle Scholar
- Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63:1055–68 .PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Measles—California, December 2014–February 2015. MMWR Morb Mortal Wkly Rep. 2015;64:153–4 .PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Measles—United States, January 1–May 23, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:496–9 .PubMedGoogle Scholar
- Richard JL, Masserey Spicher V. Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe. Euro Surveill. 2009;14:19443 .PubMedGoogle Scholar
- Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis. 2006;42:315–9. DOIPubMedGoogle Scholar
- Salathé M, Bonhoeffer S. The effect of opinion clustering on disease outbreaks. J R Soc Interface. 2008;5:1505–8 and. DOIPubMedGoogle Scholar